连豆清脉颗粒对日本大耳白兔AS斑块的干预作用及对PARP-1的影响

来源 :中国实验方剂学杂志 | 被引量 : 0次 | 上传用户:raincy
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的:研究连豆清脉颗粒对日本大耳白兔动脉粥样硬化(AS)斑块的干预作用及多聚二磷酸腺苷核糖聚合酶-1(poly adenosine diphosphate ribose polymerase-1,PARP-1)的影响。方法:取健康清洁级雄性日本大耳白兔40只,随机抽取8只日本大耳白兔为空白组,以标准饲料喂养。其余32只日本大耳白兔采用高脂饲料喂养及牛血清白蛋白静脉注射建立AS斑块模型,成功建模的兔按照随机数字表,随机分成高脂组11只(实验过程中死亡2只)、连豆清脉方组8只,辛伐他汀组8只,分别予以高脂、连豆清脉方药物、辛伐他汀药物饲料喂养,给药剂量为辛伐他汀1 mg·kg~(-1)·d~(-1),连豆清脉方3.7 g·kg~(-1)·d~(-1),8周后,检测兔AS斑块面积,PARP-1阳性表达及Toll样受体-4(Toll like receptor-4,TLR-4)mRNA,核转录因子-κB(nuclear factor kappa-B,NF-κB),血清白细胞介素-6(interleukin-6,IL-6)水平。结果:空白组没有出现AS斑块,连豆清脉方组AS斑块明显,但是明显低于高脂组;与空白组比较,连豆清脉方组主动脉AS斑块面积比例,组织PARP-1阳性细胞表达率,TLR-4 mRNA表达,NF-κB及IL-6水平均显著升高(P<0.01)。与高脂组比较,连豆清脉方组主动脉AS斑块面积比例,组织PARP-1阳性细胞表达率,TLR-4 mRNA表达,NF-κB及IL-6水平显著下降(P<0.01)。结论:连豆清脉方可抑制AS斑块的增生;其机制可能与抑制PARP-1表达等炎症反应有关。 Objective: To study the intervention of Jiedou Qingmai Granule on atherosclerosis (AS) plaques of Japanese white rabbits and the effect of poly adenosine diphosphate ribose polymerase-1 (PARP-1) )Impact. Methods: Forty male Japanese white rabbits with healthy and clean grade were randomly selected. Eight Japanese white rabbits were randomly selected as blank group and fed with standard diet. The remaining 32 Japanese white rabbits were fed with high-fat diet and bovine serum albumin intravenously to establish the AS plaque model. The rabbits successfully modeled were randomly divided into 11 groups according to a random number table: 2 in the hyperlipidemia group (2 in the experiment ), 8 in the Liantang Recipe group, and 8 in the Simvastatin group were fed with high fat, Loudou Recipe and Simvastatin respectively. The rats were given simvastatin 1 mg · kg ~ (-1) (-1) · d ~ (-1) and 3.7 g · kg ~ (-1) · d ~ (-1) respectively. After 8 weeks, the area of ​​plaque, the expression of PARP-1 and the expression of PARP- Toll-like receptor 4 (TLR-4) mRNA, nuclear factor kappa-B (NF-κB), interleukin-6 )Level. Results: There were no AS plaques in the blank group, and the AS plaque in the Liantou Qingmai prescription group was significantly lower than that in the high-fat diet group. Compared with the blank control group, the AS plaque area proportion in the aorta and the PARP 1 positive cells, TLR-4 mRNA expression, NF-κB and IL-6 levels were significantly increased (P <0.01). Compared with the hyperlipidemia group, the proportion of AS plaque area, the expression of PARP-1 positive cells, the expression of TLR-4 mRNA, the levels of NF-κB and IL-6 in Liaozhuanmai prescription group decreased significantly (P <0.01) . Conclusion: Liantao Qingmai can inhibit the proliferation of AS plaque; its mechanism may be related to the inhibition of PARP-1 expression and other inflammatory responses.
其他文献
请下载后查看,本文暂不支持在线获取查看简介。 Please download to view, this article does not support online access to view profile.
请下载后查看,本文暂不支持在线获取查看简介。 Please download to view, this article does not support online access to view profile.
期刊
葛兰素制药公司研发的retapamulin(瑞他帕林)凝胶剂(商品名:Altabax)于2007年4月获得美国FDA批准,用于治疗金葡菌或化脓性链球菌感染引起的脓疱疮。Retapamulin属于半合成的
Objective:To perform phytochemical screening,estimate total phenolics,flavonoids and to evaluate antioxidant potential of Moringa peregrina(M.peregrina) leaves.
本实验采用光电比浊法对49例接受同位素131I治疗甲亢患者进行非刺激性全唾液中溶菌酶含量测定,并和正常人对照组比较。结果显示,甲亢病人组唾液溶菌酶含量;治疗前与对照组比较无显著差
双重滤过血浆置换(DFPP)系通过将一级分离产生的致病血浆进行二级分离,弃除致病因子后的血浆与血液有形成分一同输回体内,达到治疗疾病目的的一种血浆成分分离疗法,较之单纯的血浆置换
一个风和日丽的上午,在美国康州首府奥克西尼,我们见到了康州大学爱德华教授。他,满头银丝似的白发,微胖,非常健谈而风趣。他是立陶宛人在美国的第一代移民,在美国出生,主要
本文报告11例静滴羟乙基淀粉(706代血浆)致渗透性肾 病。 1一般资料 男8例,女3例;年龄16~40岁,平均27岁。均符合中 华医学会肾脏病学会1992年制定的肾病综合征诊断标准,为 原发性,每例均行肾穿刺病理检
请下载后查看,本文暂不支持在线获取查看简介。 Please download to view, this article does not support online access to view profile.
请下载后查看,本文暂不支持在线获取查看简介。 Please download to view, this article does not support online access to view profile.